Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan Guo

Showing results (591-600 of 631) with videos related to

Pageof 64
Sort By:
BMC Cancer|August 25, 2017
Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control studyYang Li, Qiu-Yan Chen, Lin-Quan Tang, et al.
The European Respiratory Journal|June 10, 2020
Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertensionYang-Yang He, Yi Yan, Xin Jiang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2021
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinomaJin-Jie Yan, Shan-Shan Guo, Da-Feng Lin, et al.
Journal of Cancer|May 29, 2018
The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort studySai-Lan Liu, Lin-Quan Tang, Qiu-Yan Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNALi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2019
The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012Xue-Song Sun, Sai-Lan Liu, Mei-Juan Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025
GFH018 and toripalimab combination therapy for previously treated recurrent or metastatic nasopharyngeal carcinoma: Results from a phase 1b/2 studyLin-Quan Tang, Sai-Lan Liu, Muh-Hwa Yang, et al.
Cancer Letters|October 12, 2019
RETRACTED: Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasisShan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.
British Journal of Cancer|September 2, 2025
Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive studyFu-Sheng Liu, Ying-Yi Liu, Shi-Kun Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2023
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patientsYu-Jing Liang, Qiu-Yan Chen, Jing-Xiao Xu, et al.
Pageof 64

Showing results (591-600 of 631) with videos related to

Sort By:
Pageof 64
BMC Cancer|August 25, 2017
Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control studyYang Li, Qiu-Yan Chen, Lin-Quan Tang, et al.
The European Respiratory Journal|June 10, 2020
Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertensionYang-Yang He, Yi Yan, Xin Jiang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2021
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinomaJin-Jie Yan, Shan-Shan Guo, Da-Feng Lin, et al.
Journal of Cancer|May 29, 2018
The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort studySai-Lan Liu, Lin-Quan Tang, Qiu-Yan Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNALi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2019
The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012Xue-Song Sun, Sai-Lan Liu, Mei-Juan Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025
GFH018 and toripalimab combination therapy for previously treated recurrent or metastatic nasopharyngeal carcinoma: Results from a phase 1b/2 studyLin-Quan Tang, Sai-Lan Liu, Muh-Hwa Yang, et al.
Cancer Letters|October 12, 2019
RETRACTED: Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasisShan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.
British Journal of Cancer|September 2, 2025
Lipidomic profiling of human bile distinguishes cholangiocarcinoma from benign bile duct diseases with high specificity and sensitivity: a prospective descriptive studyFu-Sheng Liu, Ying-Yi Liu, Shi-Kun Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2023
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patientsYu-Jing Liang, Qiu-Yan Chen, Jing-Xiao Xu, et al.
Pageof 64